You have already added 0 works in your ORCID record related to the merged Research product.
You have already added 0 works in your ORCID record related to the merged Research product.
Pharmacological effects and molecular mechanisms of action of a herbal medicine based on Vitex agnus-castus
Copyright policy )Publishing House ABV PressPharmacological effects and molecular mechanisms of action of a herbal medicine based on Vitex agnus-castus
Dyshormonal breast dysplasia is the most frequent pathology encountered by practitioners. The interest of clinicians to these processes is associated with several factors. On the one hand effective treatment, relieves symptoms, ensures the quality of life. On the other hand, mastitis is a risk factor for subsequent malignant tumor. Therefore, timely correction is a variant of primary prevention of breast cancer. The choice of the adequate tactics of conducting such patients from the existing diversity of dosage forms is the key to success. The paper discusses the main molecular mechanisms that are implemented with the use of the drug Mastodynon.
Microsoft Academic Graph classification: Mastodynon Primary prevention Intensive care medicine medicine.medical_specialty medicine Breast cancer medicine.disease Gynecology Breast dysplasia business.industry business Effective treatment Risk factor Mastitis
Pharmacology (medical), Obstetrics and Gynecology, Radiology, Nuclear Medicine and imaging, Oncology, Surgery, dishormonal dysplasia, mastalgia, mastopathy, mastodynia, hyperprolactinemia, opioid receptors, receptors to estrogens, dopamine receptors, mastodynon, Gynecology and obstetrics, RG1-991
Pharmacology (medical), Obstetrics and Gynecology, Radiology, Nuclear Medicine and imaging, Oncology, Surgery, dishormonal dysplasia, mastalgia, mastopathy, mastodynia, hyperprolactinemia, opioid receptors, receptors to estrogens, dopamine receptors, mastodynon, Gynecology and obstetrics, RG1-991
Microsoft Academic Graph classification: Mastodynon Primary prevention Intensive care medicine medicine.medical_specialty medicine Breast cancer medicine.disease Gynecology Breast dysplasia business.industry business Effective treatment Risk factor Mastitis
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).2 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).2 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!
Dyshormonal breast dysplasia is the most frequent pathology encountered by practitioners. The interest of clinicians to these processes is associated with several factors. On the one hand effective treatment, relieves symptoms, ensures the quality of life. On the other hand, mastitis is a risk factor for subsequent malignant tumor. Therefore, timely correction is a variant of primary prevention of breast cancer. The choice of the adequate tactics of conducting such patients from the existing diversity of dosage forms is the key to success. The paper discusses the main molecular mechanisms that are implemented with the use of the drug Mastodynon.